Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2017 1
2018 1
2019 2
2021 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Canadian real-world experience of asciminib treatment in heavily pre-treated chronic myeloid leukemia (CML) patients who failed multiple lines of tyrosine kinase inhibitor (TKI) therapy.
Khadadah FM, Cerquozzi S, Olney HJ, Fraga C, Dudebout J, Xenocostas A, Finn N, Ethier V, Savoie ML, Busque L, Jamani K, Kuruvilla P, Faught C, Leber B, Kaedbey R, Assouline SE, Kim D. Khadadah FM, et al. Among authors: dudebout j. Leuk Res. 2023 Oct;133:107374. doi: 10.1016/j.leukres.2023.107374. Epub 2023 Aug 22. Leuk Res. 2023. PMID: 37657146
Transfusion Camp: a prospective evaluation of a transfusion education program for multispecialty postgraduate trainees.
Lin Y, Tilokee E, Chargé S, Alam A, Cserti-Gazdewich C, Lau W, Lee C, Lieberman L, Nixon P, Owens W, Pavenski K, Pendergrast J, Saidenberg E, Shehata N, Skeate R, Yi QL, Conrad D, Dudebout J, Hsia CC, Murphy M, Prokopchuk-Gauk O, Shah A, Solh Z, Trudeau J, Zeller MP, Callum J. Lin Y, et al. Among authors: dudebout j. Transfusion. 2019 Jun;59(6):2141-2149. doi: 10.1111/trf.15284. Epub 2019 Apr 4. Transfusion. 2019. PMID: 30946497
Acquired hemophilia A presenting post partum.
Mytopher K, Dudebout J, Card R, Gilliland B. Mytopher K, et al. Among authors: dudebout j. CMAJ. 2007 Aug 14;177(4):339-40. doi: 10.1503/cmaj.070414. CMAJ. 2007. PMID: 17698819 Free PMC article. No abstract available.
A descriptive cost-analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high-dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma.
Monteith BE, Venner CP, Cheung MC, Pater J, Shepherd L, Richardson H, Reece D, Gul E, Lalancette M, Castonguay V, Kukreti V, Tiedemann R, Phua C, Bhella S, Dudebout J, Sherry M, Yen H, Chen BE, Hay AE. Monteith BE, et al. Among authors: dudebout j. Eur J Haematol. 2021 Sep;107(3):333-342. doi: 10.1111/ejh.13671. Epub 2021 Jun 23. Eur J Haematol. 2021. PMID: 34053112 Clinical Trial.